First described by Sir James Paget in 1877, Paget's disease of bone (PDB) is a chronic bone disorder characterized by excessive and disorganized bone remodeling [1] . It may involve a single bone (monostotic) or multiple bones (polyostotic). PDB predominantly affects the elderly and is the second most common metabolic bone disease after osteoporosis. The prevalence of PDB is the highest in the United Kingdom and Western Europe, and is common in populations of British descent [1, 2] . The etiology of PDB is unclear, but genetic and environmental factors have been associated with the development of this disorder [2, 3] . Imaging is essential in establishing the diagnosis and to assess the extent of the disease [2] . Patients with symptomatic disease should be treated and bisphosphonates are the treatment of choice. Serum ALP, the most commonly used marker of disease activity in PDB, should be measured periodically once remission of PDB has been achieved to monitor for relapse of the disorder [2, 3] .
